Department of Nutrition and Drug Research, Faculty of Health Sciences, Institute of Public Health, Jagiellonian University Medical College, Kraków, Poland.
1 paper in the library · 4 citations · publishing 2023
Psilocybin shows promise in early clinical trials for treating major depressive disorder and treatment-resistant depression, with effects appearing relatively quickly after administration. However, large phase III trials are still needed to confirm its efficacy and safety before it can be approved and accepted by physicians and patients.